195 related articles for article (PubMed ID: 31499423)
21. Validation of a GC-MS screening method for anabolizing agents in aqueous nutritional supplements.
Thuyne WV; Delbeke FT
J Chromatogr Sci; 2005 Jan; 43(1):2-6. PubMed ID: 15808000
[TBL] [Abstract][Full Text] [Related]
22. Investigations into the feasibility of routine ultra high performance liquid chromatography-tandem mass spectrometry analysis of equine hair samples for detecting the misuse of anabolic steroids, anabolic steroid esters and related compounds.
Gray BP; Viljanto M; Bright J; Pearce C; Maynard S
Anal Chim Acta; 2013 Jul; 787():163-72. PubMed ID: 23830435
[TBL] [Abstract][Full Text] [Related]
23. Improvement in steroid screening for doping control with special emphasis on stanozolol.
Huenerbein A; Sipoli Marques MA; Pereira Ados S; de Aquino Neto FR
J Chromatogr A; 2003 Jan; 985(1-2):375-86. PubMed ID: 12580506
[TBL] [Abstract][Full Text] [Related]
24. Stanozolol-N-glucuronide metabolites in human urine samples as suitable targets in terms of routine anti-doping analysis.
Göschl L; Gmeiner G; Gärtner P; Stadler G; Enev V; Thevis M; Schänzer W; Guddat S; Forsdahl G
Drug Test Anal; 2021 Sep; 13(9):1668-1677. PubMed ID: 34089570
[TBL] [Abstract][Full Text] [Related]
25. A novel HPLC-MRM strategy to discover unknown and long-term metabolites of stanozolol for expanding analytical possibilities in doping-control.
Wang Z; Zhou X; Liu X; Dong Y; Zhang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():250-259. PubMed ID: 27842983
[TBL] [Abstract][Full Text] [Related]
26. Research of stimulants and anabolic steroids in dietary supplements.
Baume N; Mahler N; Kamber M; Mangin P; Saugy M
Scand J Med Sci Sports; 2006 Feb; 16(1):41-8. PubMed ID: 16430680
[TBL] [Abstract][Full Text] [Related]
27. Testing for anabolic steroids in hair from two bodybuilders.
Kintz P; Cirimele V; Sachs H; Jeanneau T; Ludes B
Forensic Sci Int; 1999 May; 101(3):209-16. PubMed ID: 10404632
[TBL] [Abstract][Full Text] [Related]
28. Anabolic steroid abuse and cardiac sudden death: a pathologic study.
Fineschi V; Baroldi G; Monciotti F; Paglicci Reattelli L; Turillazzi E
Arch Pathol Lab Med; 2001 Feb; 125(2):253-5. PubMed ID: 11175645
[TBL] [Abstract][Full Text] [Related]
29. Rhabdomyolysis of the deltoid muscle in a bodybuilder using anabolic-androgenic steroids: a case report.
Farkash U; Shabshin N; Pritsch Perry M
J Athl Train; 2009; 44(1):98-100. PubMed ID: 19180225
[TBL] [Abstract][Full Text] [Related]
30. Detection, quantification and confirmation of anabolic steroids in equine plasma by liquid chromatography and tandem mass spectrometry.
Guan F; Uboh CE; Soma LR; Luo Y; Rudy J; Tobin T
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 829(1-2):56-68. PubMed ID: 16289956
[TBL] [Abstract][Full Text] [Related]
31. Effect of Stanozolol and/or Cannabis Abuse on Hypertrophic Mechanism and Oxidative Stress of Male Albino Rat Cardiac Tissue in Relation to Exercise: A Sport Abuse Practice.
Mowaad NA; Elgohary R; ElShebiney S
Cardiovasc Toxicol; 2024 Jun; 24(6):527-538. PubMed ID: 38720122
[TBL] [Abstract][Full Text] [Related]
32. Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators.
Thevis M; Schänzer W
Handb Exp Pharmacol; 2010; (195):99-126. PubMed ID: 20020362
[TBL] [Abstract][Full Text] [Related]
33. In a Case of Death Involving Steroids, Hair Testing is More Informative than Blood or Urine Testing.
Kintz P; Gheddar L; Blanchot A; Ameline A; Raul JS
J Anal Toxicol; 2021 Sep; 45(8):829-834. PubMed ID: 33991187
[TBL] [Abstract][Full Text] [Related]
34. Myocardial infarction in a 17-year-old body builder using clenbuterol.
Kierzkowska B; Stańczyk J; Kasprzak JD
Circ J; 2005 Sep; 69(9):1144-6. PubMed ID: 16127201
[TBL] [Abstract][Full Text] [Related]
35. Effect of testosterone cypionate and stanozolol on the heart of young trained mice: A morphometric study.
Vieira TM; Rossi Junior WC; Da Ré Guerra F; Damião B; Marques PP; Esteves A
Steroids; 2019 May; 145():19-22. PubMed ID: 30772437
[TBL] [Abstract][Full Text] [Related]
36. Manifestation of severe coronary heart disease after anabolic drug abuse.
Mewis C; Spyridopoulos I; Kühlkamp V; Seipel L
Clin Cardiol; 1996 Feb; 19(2):153-5. PubMed ID: 8821428
[TBL] [Abstract][Full Text] [Related]
37. Ischemic stroke related to anabolic abuse.
Santamarina RD; Besocke AG; Romano LM; Ioli PL; Gonorazky SE
Clin Neuropharmacol; 2008; 31(2):80-5. PubMed ID: 18382179
[TBL] [Abstract][Full Text] [Related]
38. Acute myocardial infarction in a young bodybuilder taking anabolic androgenic steroids: A case report and critical review of the literature.
Christou GA; Christou KA; Nikas DN; Goudevenos JA
Eur J Prev Cardiol; 2016 Nov; 23(16):1785-1796. PubMed ID: 27184497
[TBL] [Abstract][Full Text] [Related]
39. Simple Synthesis of 17-β-
Casati S; Ottria R; Ciuffreda P
Molecules; 2020 Apr; 25(9):. PubMed ID: 32357494
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of boldenone and stanozolol and the results of quantification of anabolic and androgenic steroids in race horses and nonrace horses.
Soma LR; Uboh CE; Guan F; McDonnell S; Pack J
J Vet Pharmacol Ther; 2007 Apr; 30(2):101-8. PubMed ID: 17348894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
